The Late-Life Depression - L-DOPA study

Participants in the LLDOPA study are helping us to understand the way that dopamine (a common neurotransmitter) influences the speed of walking and thinking in later-life depression, knowledge which will help us identify the most effective treatment for each person with this condition.

Benefits to participating in this study include:

• A comprehensive assessment of mental, physical, and cognitive health

• Close monitoring and support by a geriatric psychiatrist and research team during an individualized medication trial for depression

• The opportunity to receive a special medication that stimulates the dopamine system, which may improve walking and thinking speed associated with later-life depression

• Reimbursement for travel expenses

For more information: 

• Ask for a referral from your Primary Care Provider

• Contact Dr. Iva Cheung (Research Coordinator) at icheung3@providencehealth.bc.ca

• Contact us at the clinic